Selective aortic arch perfusion: Difference between revisions
Content deleted Content added
←Created page with ''''Selective aortic arch perfusion''' ('''SAAP''') is an experimental treatment for haemorrhage-induced traumatic cardiac arrest. It has been shown in animals models to be superior to Zone 1 REBOA once cardiac arrest has occurred.<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526509/</ref> ==References== {{Reflist}}' |
ce |
||
| Line 1: | Line 1: | ||
'''Selective aortic arch perfusion''' ('''SAAP''') is an experimental treatment for [[haemorrhage]]-induced [[traumatic cardiac arrest]]. It has been shown in |
'''Selective aortic arch perfusion''' ('''SAAP''') is an experimental treatment for [[haemorrhage]]-induced [[traumatic cardiac arrest]]. It has been shown in animal studies to be superior to Zone 1 [[REBOA]] once cardiac arrest has occurred.<ref>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526509/</ref> |
||
==References== |
==References== |
||
Revision as of 22:51, 21 April 2022
Selective aortic arch perfusion (SAAP) is an experimental treatment for haemorrhage-induced traumatic cardiac arrest. It has been shown in animal studies to be superior to Zone 1 REBOA once cardiac arrest has occurred.[1]